Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimally Invasive Lung Adenocarcinoma”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Testing effectiveness (Phase 2)Study completedNCT00416650
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT00028938
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 1
Large-scale testing (Phase 3)Study completedNCT00499330
What this trial is testing

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 701
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00384826
What this trial is testing

Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma

Who this might be right for
Adenocarcinoma, Bronchiolo-Alveolar
Intergroupe Francophone de Cancerologie Thoracique 133
Early research (Phase 1)Study completedNCT00004930
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01344824
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00087438
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 59
Testing effectiveness (Phase 2)Ended earlyNCT00265785
What this trial is testing

S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 27
Testing effectiveness (Phase 2)Ended earlyNCT00003494
What this trial is testing

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

Who this might be right for
Bronchial Alveolar; Tumor
Burzynski Research Institute 4
Testing effectiveness (Phase 2)Study completedNCT00126581
What this trial is testing

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more
National Cancer Institute (NCI) 188
Early research (Phase 1)Ended earlyNCT00042835
What this trial is testing

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00049543
What this trial is testing

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
National Cancer Institute (NCI) 503
Early research (Phase 1)Study completedNCT00009789
What this trial is testing

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 39
Not applicableNot Yet RecruitingNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Not applicableEnded earlyNCT01946100
What this trial is testing

Treatment of Multifocal Lung Adenocarcinoma

Who this might be right for
Lung NeoplasmsCarcinoma Non-small-cell LungAdenocarcinoma
Mayo Clinic 100
Large-scale testing (Phase 3)Study completedNCT00021060
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 842
Testing effectiveness (Phase 2)Study completedNCT00033553
What this trial is testing

Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)Study completedNCT00293280
What this trial is testing

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Load More Results